Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases.
Journal: Journal of medicinal chemistry
Published: July 16, 2020
Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness.
Journal: Nature
Published: December 23, 2015
Utilizing Chemical Genomics to Identify Cytochrome b as a Novel Drug Target for Chagas Disease.
Journal: PLoS pathogens
Published: February 17, 2015
Showing 1-3 of 3
Last Updated: 09/26/2026